{
    "clinical_study": {
        "@rank": "119297", 
        "arm_group": {
            "arm_group_label": "Linagliptin"
        }, 
        "brief_summary": {
            "textblock": "This is a prospective, non-interventional, open label, multi center, post marketing\n      surveillance study designed to assess the safety, tolerability and efficacy of Linagliptin\n      among Filipino patients with type 2 Diabetes Mellitus (DM) within the study duration of 24\n      weeks."
        }, 
        "brief_title": "Linagliptin Among Filipino Patients With Type 2 Diabetes Mellitus", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Diabetes Mellitus, Type 2", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          1. Filipino of Asian race\n\n          2. Patient using Linagliptin within label or locally approved indication.  The\n             prescription of Linagliptin to the patient must be in the course of normal clinical\n             practice and independent of the decision to include the patient in the study.\n\n          3. Male or female patients more than 18 years old\n\n          4. Body mass index less than or equal to 40\n\n          5. Diagnosed with type 2 DM\n\n          6. Uncontrolled type 2 DM with fasting blood sugar of more than 126 mg/dl and/or HbA1c\n             more than 7%.\n\n        Exclusion criteria:\n\n          1. Diagnosed with type 1 DM\n\n          2. Patients with acute illness requiring hospitalization in the past one month\n\n          3. Patients participating in a different study that includes an investigational drug\n\n          4. Patients with known hypersensitivity reaction to Linagliptin or any of tis components\n\n          5. Pregnant women and those women who have intentions of getting pregnant within the\n             study duration\n\n          6. Nursing women\n\n          7. Patients with concomitant conditions that contraindicates Linagliptin use as\n             described in its product information"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Filipino type 2 DM patients"
            }
        }, 
        "enrollment": {
            "#text": "918", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01826370", 
            "org_study_id": "1218.94"
        }, 
        "intervention": {
            "arm_group_label": "Linagliptin", 
            "description": "tablet", 
            "intervention_name": "Linagliptin", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "BI 1356"
        }, 
        "lastchanged_date": "January 21, 2014", 
        "link": {
            "description": "Related Info", 
            "url": "http://trials.boehringer-ingelheim.com/content/dam/internet/opu/clinicaltrial/com_EN/results/1218/1218.94_statement_disc.pdf"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Agoo, La Union", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 43"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Angeles City, Pampanga", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 40"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Angono, Rizal", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 31"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Antipolo, Rizal", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 32"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aparri, Cagayan", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 27"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Batangas", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 4"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Butuan City, Agusan del Norte", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 48"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cabanatuan, Nueva Ecija", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 12"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cagayan de Oro", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 23"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caloocan", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 3"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cardona, Rizal", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 42"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cebu", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 25"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dagupan, Pangasinan", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 44"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Iligan City, Lanao del Norte", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 49"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Iloilo", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 2"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Iriga City, Camarines Sur", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 45"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Laoag, Ilocos Norte", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 20"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Pinas", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 24"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Legazpi, Albay", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 7"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lucena, Quezon", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 35"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Makati", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 1"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Malolos, Bulacan", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 39"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mandaluyong City", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 37"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manila", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 28"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marikina", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 5"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Meycauyan, Bulacan", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 16"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Naga City, Camarines Sur", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 47"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Olongapo", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 15"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pampanga", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 10"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paranaque", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 19"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pasay City", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 51"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pasig", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 30"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Puerto Princesa, Palawan", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 34"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Quezon City", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 26"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rosales, Pangasinan", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 11"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Fernando, La Union", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 21"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Fernando, Pampanga", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 9"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Jose, Nueva Ecija", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 13"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Juan", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 29"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Pablo, Laguna", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 8"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Pedro, Laguna", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 50"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santiago city, Isabela", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 41"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sogod, Southern Leyte", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 36"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sta.Maria, Bulacan", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 38"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tacloban", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 6"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tagbilaran, Bohol", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 33"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tuguegarao, Cagayan", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 14"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Urdaneta, Pangasinan", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 18"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valencia City Bukidnon", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 46"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valenzuela, Bulacan", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 17"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zamboanga", 
                        "country": "Philippines"
                    }, 
                    "name": "Boehringer Ingelheim Investigational Site 22"
                }
            }
        ], 
        "location_countries": {
            "country": "Philippines"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Post-Marketing Surveillance Study on the Safety, Tolerability and Efficacy of Linagliptin Among Filipino Patients With Type 2 Diabetes Mellitus", 
        "overall_official": {
            "affiliation": "Boehringer Ingelheim", 
            "last_name": "Boehringer Ingelheim", 
            "role": "Study Chair"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "Philippines: Bureau of Food and Drugs"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Safety endpoints are frequency of adverse events and serious adverse events in an actual clinical setting, including hypoglycemic events.", 
            "safety_issue": "Yes", 
            "time_frame": "Up to 24 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01826370"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline to endpoint of glycosylated hemoglobin", 
                "safety_issue": "No", 
                "time_frame": "Up to 24 weeks"
            }, 
            {
                "measure": "Change from baseline to endpoint of fasting blood sugar", 
                "safety_issue": "No", 
                "time_frame": "Up to 24 weeks"
            }
        ], 
        "source": "Boehringer Ingelheim", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boehringer Ingelheim", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}